BAC
Bank of America Corporation
BAC's outlook is improving, though it still trails on the overall score.
SCHW
The Charles Schwab Corporation
SCHW has the edge over BAC overall, supported by stronger valuation and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SCHW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
SCHW's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like SCHW.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SCHW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $91.72 | — |
| Cheap | 16x | $95.94 | +4.6% |
| Current | 16x | $91.72 | — |
| Fair | 24x | $140 | +52% |
| Expensive | 30x | $178 | +94% |
Historical ranges are pointers, not guarantees.
SCHW has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SCHW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for SCHW, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
SCHW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.48 | +28% |
| Q3 2026 | $5.85 | +37% |
| Q2 2026 | $5.49 | +48% |
| Q1 2026 | $5.03 | +52% |
| Q4 2025 | $4.65 | +56% |
| Q3 2025 | $4.27 | +67% |
| Q2 2025 | $3.72 | +54% |
| Q1 2025 | $3.30 | +38% |
| Q4 2024 | $2.99 | +18% |
SCHW has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SCHW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2B | +17% |
| Q2 2026 | $7.1B | +21% |
| Q1 2026 | $6.5B | +16% |
| Q4 2025 | $6.3B | +19% |
| Q3 2025 | $6.1B | +27% |
| Q2 2025 | $5.9B | +25% |
| Q1 2025 | $5.6B | +18% |
| Q4 2024 | $5.3B | +20% |
SCHW has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 53% | +3.4 points |
| Q2 2026 | 52% | +4 points |
| Q1 2026 | 49% | +5.3 points |
| Q4 2025 | 50% | +6.9 points |
| Q3 2025 | 49% | +11 points |
| Q2 2025 | 48% | +11 points |
| Q1 2025 | 44% | +5.9 points |
| Q4 2024 | 43% | +17 points |
SCHW has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SCHW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +231% |
| Q2 2026 | $4.1B | +35% |
| Q1 2026 | $7.2B | +15% |
| Q4 2025 | -$921M | +$10.2B |
| Q3 2025 | $393M | -98% |
| Q2 2025 | $3B | +$7.4B |
| Q1 2025 | $6.2B | +$7.7B |
| Q4 2024 | -$11.1B | -155% |
SCHW has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SCHW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SCHW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -6M shares |
| 1 year | -4.3% | -78M shares |
| 3 years | -5.1% | -94M shares |
| 5 years | -8.7% | -165M shares |
| Available history | +34% | +440M shares |
SCHW has 1.7B diluted shares, down 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $500M |
| Q2 2026 | $999M |
| Q1 2026 | $2.4B |
| Q1 2025 | $1.5B |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SCHW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -5.4x | Net Cash |
| Q1 2020 | -12.0x | Net Cash |
| Q4 2019 | -4.2x | Net Cash |
SCHW has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like SCHW.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SCHW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.9 | Neutral |
| Stochastic | 11.2 | Oversold |
SCHW's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SCHW on valuation relative to its sector.
SCHW PE vs Financial Services Sector
| Metric | SCHW | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 20% above |
| PE % | 14 | 63 | 49 pts below |
SCHW is trading at 16x earnings, a 20% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SCHW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $93.3 | 1.7% below |
| 20 week MA | $100.9 | 9.1% below |
| 50 week MA | $97.3 | 5.7% below |
| 100 week MA | $92.0 | 0.3% below |
| 200 week MA | $78.5 | 17% above |
SCHW has fallen below most of its moving averages, though it's still 17% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SCHW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.3 | $52.1 | +7.7% |
| 2021 | $52.1 | $85.1 | +64% |
| 2022 | $85.1 | $81.8 | -3.9% |
| 2023 | $81.8 | $68.8 | -16% |
| 2024 | $68.8 | $74.7 | +8.6% |
| 2025 | $74.7 | $101.9 | +36% |
| 2026 YTD | $101.9 | $91.7 | -10% |
SCHW has the edge over BAC on returns for 2026, with the stronger performance.